- Home
- NEON vs ATRA Comparison
NEON vs ATRA Comparison
Compare NEON & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEON | ATRA |
|---|---|---|
| Founded | 1997 | 2012 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1M | 37.6M |
| IPO Year | 2007 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NEON | ATRA |
|---|---|---|
| Price | $1.80 | $5.07 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | $6.00 |
| AVG Volume (30 Days) | 170.5K | ★ 730.1K |
| Earning Date | 03-20-2026 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.54 | ★ 1.97 |
| Revenue | $2,197,000.00 | ★ $151,930,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $43.34 | N/A |
| P/E Ratio | $3.56 | ★ $2.56 |
| Revenue Growth | N/A | ★ 51.27 |
| 52 Week Low | $1.72 | $4.20 |
| 52 Week High | $29.90 | $19.15 |
Technical Indicators
Market Signals| Indicator | NEON | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 37.44 | 28.77 |
| Support Level | $1.77 | $4.91 |
| Resistance Level | $1.88 | $5.71 |
| Average True Range (ATR) | 0.09 | 0.47 |
| MACD | 0.01 | 0.17 |
| Stochastic Oscillator | 14.28 | 56.62 |
Price Performance
Historical ComparisonAbout NEON Neonode Inc.
Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).